Skip to main content
Erschienen in: Wiener klinische Wochenschrift 21-22/2014

01.11.2014 | original article

Fontan-like circulation as a criterion for heart transplantation in arrhythmogenic right ventricular dysplasia

verfasst von: Christiana Schernthaner, MD, Gerhard Poelzl, MD, Bernhard Strohmer, MD, Richard Steinacher, MD, Marcel Granitz, MD, Johann Altenberger, MD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 21-22/2014

Einloggen, um Zugang zu erhalten

Summary

Background

Arrhythmogenic right ventricular dysplasia (ARVD) is often associated with progressive right ventricular dysfunction. Although heart transplantation (HTx) is suggested in these patients, indication and optimal timing for listing can be challenging.

Methods and results

The study comprises four patients (two male, range: 37–56 years) with advanced ARVD who were considered for HTx. Standard inclusion criteria for HTx listing such as clinical signs, New York Heart Association (NYHA) classification (II-III), and N-terminal pro-brain natriuretic peptide (NT-proBNP) (3672 ± 1407 pg/ml) were heterogeneous and did not add unequivocally to decision making. In all patients, though, right heart hemodynamics revealed Fontan-like circulation (FLC) with equilibrated pressure tracings between the right atrium (16 ± 4 mmHg) and the pulmonary artery (16 ± 5 mmHg). In this condition, the pulmonary blood flow can be regarded as nearly non-pulsatile, as it is passive and propelled by the transpulmonary gradient and intrathoracic pressure alterations produced by breathing to the left atrium. Based on these findings, all patients were listed for HTx and were finally successfully transplanted.

Conclusions

In patients with ARVD, evidence of FLC may serve as an additional criterion for HTx. This applies particularly to patients who do not clearly fulfill standard transplant criteria and to patients with electrical instability.
Literatur
1.
Zurück zum Zitat Lemola K, Brunckhorst C, Helfenstein U, Oechslin E, Jenni R, Duru F. Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: long term experience of a tertiary care centre. Heart. 2005;91:1167–72.PubMedCentralPubMedCrossRef Lemola K, Brunckhorst C, Helfenstein U, Oechslin E, Jenni R, Duru F. Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: long term experience of a tertiary care centre. Heart. 2005;91:1167–72.PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Gemayel C, Pelliccia A, Thompson PD. Arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol. 2001;38:1773–81. Review. Gemayel C, Pelliccia A, Thompson PD. Arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol. 2001;38:1773–81. Review.
3.
Zurück zum Zitat Kullo IJ, Edwards WD, Seward JB. Right ventricular dysplasia: the Mayo Clinic experience. Mayo Clin Proc. 1995;70:541–8.PubMedCrossRef Kullo IJ, Edwards WD, Seward JB. Right ventricular dysplasia: the Mayo Clinic experience. Mayo Clin Proc. 1995;70:541–8.PubMedCrossRef
4.
Zurück zum Zitat Sen-Chowdhry S, Syrris P, Ward D, Asimaki A, Sevdalis E, McKenna WJ. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation. 2007;115:1710–20.PubMedCrossRef Sen-Chowdhry S, Syrris P, Ward D, Asimaki A, Sevdalis E, McKenna WJ. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation. 2007;115:1710–20.PubMedCrossRef
5.
Zurück zum Zitat Pinamonti B, Sinagra G, Salvi A, et al. Left ventricular involvement in right ventricular dysplasia. Am Heart J. 1992;123:711–24.PubMedCrossRef Pinamonti B, Sinagra G, Salvi A, et al. Left ventricular involvement in right ventricular dysplasia. Am Heart J. 1992;123:711–24.PubMedCrossRef
6.
Zurück zum Zitat Piccini JP, Dalal D, Roguin A, et al. Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. Heart Rhythm. 2005;2:1188–94.PubMedCrossRef Piccini JP, Dalal D, Roguin A, et al. Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. Heart Rhythm. 2005;2:1188–94.PubMedCrossRef
7.
Zurück zum Zitat Dalal D, Nasir K, Bomma C, et al. Arrhythmogenic right ventricular dysplasia: a United States experience. Circulation. 2005;112:3823–32.PubMedCrossRef Dalal D, Nasir K, Bomma C, et al. Arrhythmogenic right ventricular dysplasia: a United States experience. Circulation. 2005;112:3823–32.PubMedCrossRef
8.
Zurück zum Zitat Hulot JS, Jouven X, Empana JP, Frank R, Fontaine G. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation. 2004;110:1879–84. Review. Hulot JS, Jouven X, Empana JP, Frank R, Fontaine G. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation. 2004;110:1879–84. Review.
9.
Zurück zum Zitat Corrado D, Leoni L, Link MS, et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation. 2003;108:3084–91.PubMedCrossRef Corrado D, Leoni L, Link MS, et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation. 2003;108:3084–91.PubMedCrossRef
10.
Zurück zum Zitat Yancy CW, Jessup M, Bozkurt B, et al. ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62:147–239.CrossRef Yancy CW, Jessup M, Bozkurt B, et al. ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62:147–239.CrossRef
11.
Zurück zum Zitat Mehra MR, Kobashigawa J, Starling R, et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates. J Heart Lung Transplant. 2006;25:1024–42.PubMedCrossRef Mehra MR, Kobashigawa J, Starling R, et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates. J Heart Lung Transplant. 2006;25:1024–42.PubMedCrossRef
12.
Zurück zum Zitat Galiè N, Hoeper MM, Humbert M, ESC Committee for Practice Guidelines (CPG), et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009;30:2493–537.PubMedCrossRef Galiè N, Hoeper MM, Humbert M, ESC Committee for Practice Guidelines (CPG), et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009;30:2493–537.PubMedCrossRef
13.
Zurück zum Zitat Gilljam T, Bergh CH. Right ventricular cardiomyopathy: timing of heart transplantation in Uhl’s anomaly and arrythmogenic right ventricular cardiomyopathy. Eur J Heart Fail. 2009;11:106–9.PubMedCrossRef Gilljam T, Bergh CH. Right ventricular cardiomyopathy: timing of heart transplantation in Uhl’s anomaly and arrythmogenic right ventricular cardiomyopathy. Eur J Heart Fail. 2009;11:106–9.PubMedCrossRef
14.
Zurück zum Zitat Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation. 2010;121(13):1533–41.PubMedCentralPubMedCrossRef Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation. 2010;121(13):1533–41.PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Pepine CJ, Hill JA, Lambert CR. Diagnostic and therapeutic cardiac catheterization. 3rd ed. Baltimore: Willians & Wilkins; 1998. Pepine CJ, Hill JA, Lambert CR. Diagnostic and therapeutic cardiac catheterization. 3rd ed. Baltimore: Willians & Wilkins; 1998.
16.
Zurück zum Zitat Pocock SJ, Ariti CA, McMurray JJ, Meta-Analysis Global Group in Chronic Heart Failure, et al. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J. 2013;34:1404–13.PubMedCrossRef Pocock SJ, Ariti CA, McMurray JJ, Meta-Analysis Global Group in Chronic Heart Failure, et al. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J. 2013;34:1404–13.PubMedCrossRef
17.
Zurück zum Zitat Tedford RJ, James C, Judge DP, et al. Cardiac transplantation in arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol. 2012;59:289–90.PubMedCentralPubMedCrossRef Tedford RJ, James C, Judge DP, et al. Cardiac transplantation in arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol. 2012;59:289–90.PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Pinamonti B, Dragos AM, Pyxaras SA, et al. Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry. Eur Heart J. 2011;32:1105–13.PubMedCrossRef Pinamonti B, Dragos AM, Pyxaras SA, et al. Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry. Eur Heart J. 2011;32:1105–13.PubMedCrossRef
Metadaten
Titel
Fontan-like circulation as a criterion for heart transplantation in arrhythmogenic right ventricular dysplasia
verfasst von
Christiana Schernthaner, MD
Gerhard Poelzl, MD
Bernhard Strohmer, MD
Richard Steinacher, MD
Marcel Granitz, MD
Johann Altenberger, MD
Publikationsdatum
01.11.2014
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 21-22/2014
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-014-0656-8

Weitere Artikel der Ausgabe 21-22/2014

Wiener klinische Wochenschrift 21-22/2014 Zur Ausgabe

Editorial

Editorial

MUW resarcher of the month

Researcher of the month